These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32145387)

  • 1. Lipocalin-type prostaglandin D
    Kumar S; Srivastava A; Palaia T; Hall C; Lee J; Stevenson M; Zhao CL; Ragolia L
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106429. PubMed ID: 32145387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-type Prostaglandin D2 Synthase appears to function as a Novel Adipokine Preventing Adipose Dysfunction in response to a High Fat Diet.
    Srivastava A; Palaia T; Hall C; Stevenson M; Lee J; Ragolia L
    Prostaglandins Other Lipid Mediat; 2021 Dec; 157():106585. PubMed ID: 34371198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-type prostaglandin D
    Kumar S; Lau R; Hall CE; Palaia T; Rideout DA; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2016; 12(8):1523-1531. PubMed ID: 27425837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice.
    Ragolia L; Palaia T; Hall CE; Maesaka JK; Eguchi N; Urade Y
    J Biol Chem; 2005 Aug; 280(33):29946-55. PubMed ID: 15970590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
    Xiao Z; Chu Y; Qin W
    Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo.
    Virtue S; Masoodi M; Velagapudi V; Tan CY; Dale M; Suorti T; Slawik M; Blount M; Burling K; Campbell M; Eguchi N; Medina-Gomez G; Sethi JK; Orešič M; Urade Y; Griffin JL; Vidal-Puig A
    PLoS One; 2012; 7(7):e39512. PubMed ID: 22792179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-PGDS-produced PGD
    Fujimori K; Aritake K; Oishi Y; Nagata N; Maehara T; Lazarus M; Urade Y
    Sci Rep; 2019 Feb; 9(1):1931. PubMed ID: 30760783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
    Lu H; Yuan X; Zhang Y; Han M; Liu S; Han K; Liang P; Cheng J
    Biomed Pharmacother; 2020 Sep; 129():110347. PubMed ID: 32535386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis hyperactivity.
    Evans JF; Islam S; Urade Y; Eguchi N; Ragolia L
    J Endocrinol; 2013 Feb; 216(2):169-80. PubMed ID: 23151358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice.
    Song WL; Ricciotti E; Liang X; Grosser T; Grant GR; FitzGerald GA
    J Pharmacol Exp Ther; 2018 Dec; 367(3):425-432. PubMed ID: 30305427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birth.
    Kumar S; Palaia T; Hall CE; Ragolia L
    Prostaglandins Other Lipid Mediat; 2015; 118-119():28-33. PubMed ID: 25964109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice.
    Tanaka R; Miwa Y; Mou K; Tomikawa M; Eguchi N; Urade Y; Takahashi-Yanaga F; Morimoto S; Wake N; Sasaguri T
    Biochem Biophys Res Commun; 2009 Jan; 378(4):851-6. PubMed ID: 19070593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
    Zhang Y; Wu B; Zhang H; Ge X; Ying S; Hu M; Li W; Huang Y; Wang L; Chen C; Shan X; Liang G
    J Cell Mol Med; 2018 Feb; 22(2):936-947. PubMed ID: 29077272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.